KIA
Kopp Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.05M | Sell |
10,578
-3,685
| -26% | -$367K | 1.94% | 18 |
|
|
2019
Q2 | $1.63M | Sell |
14,263
-4,928
| -26% | -$562K | 1.85% | 18 |
|
|
2019
Q1 | $2.41M | Sell |
19,191
-149
| -0.8% | -$18.7K | 1.95% | 20 |
|
|
2018
Q4 | $2.62M | Sell |
19,340
-137
| -0.7% | -$18.6K | 2.56% | 18 |
|
|
2018
Q3 | $5.35M | Sell |
19,477
-3,659
| -16% | -$1M | 4.5% | 7 |
|
|
2018
Q2 | $4.79M | Buy |
23,136
+1,731
| +8% | +$359K | 4.5% | 3 |
|
|
2018
Q1 | $3.54M | Sell |
21,405
-621
| -3% | -$103K | 3.59% | 4 |
|
|
2017
Q4 | $3.02M | Sell |
22,026
-20
| -0.1% | -$2.74K | 3.02% | 11 |
|
|
2017
Q3 | $3M | Sell |
22,046
-370
| -2% | -$50.4K | 2.75% | 13 |
|
|
2017
Q2 | $2.72M | Sell |
22,416
-1,148
| -5% | -$139K | 2.44% | 15 |
|
|
2017
Q1 | $2.49M | Sell |
23,564
-221
| -0.9% | -$23.4K | 2.44% | 14 |
|
|
2016
Q4 | $2.42M | Buy |
23,785
+327
| +1% | +$33.2K | 2.55% | 10 |
|
|
2016
Q3 | $2.39M | Sell |
23,458
-6,959
| -23% | -$710K | 2.37% | 14 |
|
|
2016
Q2 | $3.63M | Sell |
30,417
-717
| -2% | -$85.5K | 1.93% | 10 |
|
|
2016
Q1 | $3.33M | Buy |
31,134
+644
| +2% | +$69K | 1.82% | 11 |
|
|
2015
Q4 | $3.31M | Sell |
30,490
-1,018
| -3% | -$110K | 1.63% | 15 |
|
|
2015
Q3 | $2.7M | Buy |
31,508
+3,664
| +13% | +$314K | 1.45% | 17 |
|
|
2015
Q2 | $2.81M | Buy |
27,844
+3,343
| +14% | +$337K | 1.25% | 21 |
|
|
2015
Q1 | $1.89M | Buy |
24,501
+770
| +3% | +$59.4K | 0.84% | 28 |
|
|
2014
Q4 | $1.26M | Buy |
23,731
+5,363
| +29% | +$285K | 0.61% | 32 |
|
|
2014
Q3 | $863K | Sell |
18,368
-479
| -3% | -$22.5K | 0.43% | 48 |
|
|
2014
Q2 | $1.17M | Buy |
18,847
+13,835
| +276% | +$862K | 0.54% | 36 |
|
|
2014
Q1 | $337K | Buy |
5,012
+1,008
| +25% | +$67.8K | 0.14% | 58 |
|
|
2013
Q4 | $211K | Sell |
4,004
-39,135
| -91% | -$2.06M | 0.1% | 59 |
|
|
2013
Q3 | $1.87M | Sell |
43,139
-6,240
| -13% | -$270K | 0.69% | 31 |
|
|
2013
Q2 | $1.85M | Buy |
+49,379
| New | +$1.85M | 0.72% | 31 |
|